Pyrazinamide Tablet
Product Images NDC 0054-0812

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyrazinamide (NDC 0054-0812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (Image 01)

Structural Formula Image (Image 01)
Chemical structure of pyrazinamide, showing a pyrazine ring with two nitrogen atoms and an attached CONH2 group.*
FDA Label Image

Pyrazinamide Tabs 500mg 60s Bottle Label Image (Image 02)

Pyrazinamide Tabs 500mg 60s Bottle Label Image (Image 02)
Pyrazinamide Tablets, USP 500 mg oral tablets packaging label from Hikma Pharmaceuticals USA Inc. The label includes dosage strength (500 mg), quantity (60 tablets), NDC 0054-0812-21, storage instructions, warnings, and manufacturer details. The label features the Hikma logo in orange and blue highlight on the strength box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.